Reduced <scp>DNA</scp> methylation and hydroxymethylation in patients with systemic mastocytosis

Abstract

The correlation between SM diagnosis and significantly low 5hmC levels suggests that reduction of 5hmC represents a systemic effect of SM that may be useful for patient stratification and that measurements of 5hmC levels may serve as a better prognostic marker than TET2 mutations.

References

Page 1

	Year	Citations
Fiji: an open-source platform for biological-image analysis Johannes Schindelin, Ignacio Arganda‐Carreras, Erwin Frise, Nature Methods BiologyBiological-image AnalysisImage AnalysisEngineeringMicroscope Image Processing	2012	67.6K
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Hadi Valadi, Karin M. Ekström, Apostolos Bossios, Nature Cell Biology Novel MechanismSystems BiologyNatural SciencesExosome-mediated TransferExtracellular Microvesicles	2007	12.6K
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1 Mamta Tahiliani, Kian Peng Koh, Yinghua Shen, Science	2009	5.7K
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia Liran I. Shlush, Sasan Zandi, Amanda Mitchell, Nature Hematological MalignancyAcute LeukaemiaMedicineMixed-phenotype Acute LeukemiaHematology	2014	1.4K
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 Myunggon Ko, Yun Huang, A. Jankowska, Nature Hematological MalignancyTumor BiologyMutant Tet2Oncogenic AgentMedicine	2010	1.3K
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon Jean‐Pierre J. Issa, Yvonne Ottaviano, P Celano, Nature Genetics MedicineEpigenetic ChangeGastroenterologyColorectal CancerPathology	1994	1.2K
Loss of <i>IGF2</i> Imprinting: A Potential Marker of Colorectal Cancer Risk Hengmi Cui, Marcia Cruz‐Correa, Francis M. Giardiello, Science Cancer RiskEpigenetic RegulationMedicineGeneticsGenetic Epidemiology	2003	729
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies Omar Abdel‐Wahab, Ann Mullally, Cyrus V. Hedvat, Blood	2009	713
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation Hui Yang, Yi Liu, Feng Bai, Oncogene Tumor BiologyTet Gene ExpressionOncogenic AgentMedicineTumor Development	2012	576
The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations Yongsheng Ma, Shan Zeng, Dean D. Metcalfe, Blood	2002	447

Page 1